|
1
|
Tang H, Han X, Li M, Li T and Hao Y:
Linc00221 modulates cisplatin resistance in non-small-cell lung
cancer via sponging miR-519a. Biochimie. 162:134–143. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang T, Li J, Zhang C, Hong Q, Jiang D,
Ye M and Duan S: Distinguishing lung adenocarcinoma from lung
squamous cell carcinoma by two hypomethylated and three
hypermethylated genes: A meta-analysis. PLoS One. 11:e01490882016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu R, Mao Y, Chen K, He W, Shi W and Han
Y: The long noncoding RNA ANRIL acts as an oncogene and contributes
to paclitaxel resistance of lung adenocarcinoma A549 cells.
Oncotarget. 8:39177–39184. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang M, He X, Huang X, Wang J, He Y and
Wei L: LncRNA MIR4435-2HG-mediated upregulation of TGF-β1 promotes
migration and proliferation of nonsmall cell lung cancer cells.
Environ Toxicol. 35:582–590. 2020. View Article : Google Scholar
|
|
5
|
Zhao M, Xin XF, Zhang JY, Dai W, Lv TF and
Song Y: LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by
regulating miR-96-5p/CYLD signaling. Cancer Med. 9:1196–1208. 2020.
View Article : Google Scholar
|
|
6
|
Hu M, Zhang Q, Tian XH, Wang JL, Niu YX
and Li G: lncRNA CCAT1 is a biomarker for the proliferation and
drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1
axis. Mol Carcinog. 58:2207–2217. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yan P, Su Z, Zhang Z and Gao T: LncRNA
NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells
to cisplatin by sponging miR-9-5p and regulating SPAG9 expression.
Int J Oncol. 55:988–1002. 2019.PubMed/NCBI
|
|
8
|
Chen Z, Ju H, Zhao T, Yu S, Li P, Jia J,
Li N, Jing X, Tan B and Li Y: hsa_circ_0092306 targeting miR-197-3p
promotes gastric cancer development by regulating PRKCB in MKN-45
cells. Mol Ther Nucleic Acids. 18:617–626. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen H, Lan Z, Li Q and Li Y: Abnormal
expression of long noncoding RNA FGD5-AS1 affects the development
of periodontitis through regulating miR-142-3p/SOCS6/NF-κB pathway.
Artif Cells Nanomed Biotechnol. 47:2098–2106. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhu H, Lu J, Zhao H, Chen Z, Cui Q, Lin Z,
Wang X, Wang J, Dong H, Wang S and Tan J: Functional long noncoding
RNAs (lncRNAs) in clear cell kidney carcinoma revealed by
reconstruction and comprehensive analysis of the lncRNA-miRNA-mRNA
regulatory network. Med Sci Monit. 24:8250–8263. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun L, Liu X, Pan B, Hu X, Zhu Y, Su Y,
Guo Z, Zhang G, Xu M, Xu X, et al: Serum exosomal miR-122 as a
potential diagnostic and prognostic biomarker of colorectal cancer
with liver metastasis. J Cancer. 11:630–637. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qin Y, Zhou X, Huang C, Li L, Liu H, Liang
N, Chen Y, Ma D, Han Z, Xu X, et al: Serum miR-342-3p is a novel
diagnostic and prognostic biomarker for non-small cell lung cancer.
Int J Clin Exp Pathol. 11:2742–2748. 2018.PubMed/NCBI
|
|
13
|
Liang ZX, Liu HS, Wang FW, Xiong L, Zhou
C, Hu T, He XW, Wu XJ, Xie D, Wu XR and Lan P: LncRNA RPPH1
promotes colorectal cancer metastasis by interacting with TUBB3 and
by promoting exosomes-mediated macrophage M2 polarization. Cell
Death Dis. 10:8292019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan LY, Shi KY, Xu D, Ren LP, Yang P,
Zhang L, Wang F and Shao GL: LncRNA GIHCG regulates microRNA-1281
and promotes malignant progression of breast cancer. Eur Rev Med
Pharmacol Sci. 23:10842–10850. 2019.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Yang QS, Li B, Xu G, Yang SQ, Wang P, Tang
HH and Liu YY: Long noncoding RNA LINC00483/microRNA-144 regulates
radiosensitivity and epithelial-mesenchymal transition in lung
adenocarcinoma by interacting with HOXA10. J Cell Physiol.
234:11805–11821. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao J, Lv Y, Jin F, Liu Y, Ma Y, Xiong Y,
Liu L, Zhang S, Sun Y, Tipoe GL, et al: LncRNA HANR promotes
tumorigenesis and increase of chemoresistance in hepatocellular
carcinoma. Cell Physiol Biochem. 43:1926–1938. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang J, Xu C, Gao Y, Wang Y, Ding Z,
Zhang Y, Shen W, Zheng Y and Wan Y: A novel long non-coding RNA,
MSTRG.51053.2 regulates cisplatin resistance by sponging the
miR-432-5p in non-small cell lung cancer cells. Front Oncol.
10:2152020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng F and Xu R: CircPVT1 contributes to
chemotherapy resistance of lung adenocarcinoma through
miR-145-5p/ABCC1 axis. Biomed Pharmacother. 124:1098282020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang DY, Li N and Cui YL: Long non-coding
RNA CCAT1 sponges miR-454 to promote chemoresistance of ovarian
cancer cells to cisplatin by regulation of surviving. Cancer Res
Treat. 52:798–814. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qu W, Huang W, Yang F, Ju H and Zhu G:
Long noncoding RNA LINC00461 mediates cisplatin resistance of
rectal cancer via miR-593-5p/CCND1 axis. Biomed Pharmacother.
124:1097402020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu L, Liu C and Zhang Z: Knockdown of
lncRNA MIAT inhibits proliferation and cisplatin resistance in
non-small cell lung cancer cells by increasing miR-184 expression.
Oncol Lett. 19:533–541. 2020.PubMed/NCBI
|
|
23
|
Dai D, Feng XD, Zhu WQ and Bao YN: LncRNA
BLACAT1 regulates the viability, migration and invasion of oral
squamous cell carcinoma cells by targeting miR-142-5p. Eur Rev Med
Pharmacol Sci. 23:10313–10323. 2019.PubMed/NCBI
|
|
24
|
Li M, Cai O and Tan S: LOXL1-AS1 drives
the progression of gastric cancer via regulating miR-142-5p/PIK3CA
axis. Onco Targets Ther. 12:11345–11357. 2019. View Article : Google Scholar
|
|
25
|
Liu H, Chen R, Kang F, Lai H and Wang Y:
KCNQ1OT1 promotes ovarian cancer progression via modulating
MIR-142-5p/CAPN10 axis. Mol Genet Genomic Med.
8:e10772020.PubMed/NCBI
|
|
26
|
Li X, Chen W, Jin Y, Xue R, Su J, Mu Z, Li
J and Jiang S: miR-142-5p enhances cisplatin-induced apoptosis in
ovarian cancer cells by targeting multiple anti-apoptotic genes.
Biochem Pharmacol. 161:98–112. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang L, Zhao G, Ji S, Yuan Q and Zhou H:
Downregulated long non-coding RNA MSC-AS1 inhibits osteosarcoma
progression and increases sensitivity to cisplatin by binding to
MicroRNA-142. Med Sci Monit. 26:e9215942020.PubMed/NCBI
|
|
28
|
Kalim M, Iqbal Khan MS and Zhan J:
Programmed cell death ligand-1: A dynamic immune checkpoint in
cancer therapy. Chem Biol Drug Des. 95:552–566. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang M, Hu Z, Yue R, Yang L, Zhang B and
Chen Y: The efficacy and safety of qiming granule for dry eye
disease: A systematic review and meta-analysis. Front Pharmacol.
11:5802020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang J, Chou X, Zhuang M, Zhu C, Hu Y,
Cheng D and Liu Z: LINC00657 activates PD-L1 to promote
osteosarcoma metastasis via miR-106a. J Cell Biochem.
121:4188–4195. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xue C, Xu Y, Ye W, Xie Q, Gao H, Xu B,
Zhang D and Jiang J: Expression of PD-L1 in ovarian cancer and its
synergistic antitumor effect with PARP inhibitor. Gynecol Oncol.
157:222–233. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zuo Y, Zheng W, Liu J, Tang Q, Wang SS and
Yang XS: MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance
of ovarian cancer cells. Neoplasma. 67:93–101. 2020. View Article : Google Scholar
|
